Coya Therapeutics Inc (COYA)

Nov 16, 2024

Trend Tracker for (COYA) - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

Insider Buying: CFO David Snyder Acquires Shares of Coya Therape - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Coya therapeutics CFO David Snyder buys $12,934 in stock - Investing.com

Nov 14, 2024

Nov 14, 2024

HC Wainwright Has Positive Forecast for COYA FY2024 Earnings - MarketBeat

Nov 14, 2024

Nov 11, 2024

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 11, 2024

Nov 09, 2024

Coya Therapeutics (NASDAQ:COYA) Announces Earnings Results - MarketBeat

Nov 09, 2024

Nov 07, 2024

Meet 5 of the fastest-growing scaleup companies in Houston - InnovationMap

Nov 07, 2024

Nov 07, 2024

INNOVATIONMAP EMAILS ARE AWESOME - InnovationMap

Nov 07, 2024

Nov 07, 2024

Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at Chardan Capital - MarketBeat

Nov 07, 2024

Nov 07, 2024

Coya Therapeutics Reports Q3 2024 Highlights and Progress - TipRanks

Nov 07, 2024

Nov 06, 2024

Coya Therapeutics board member resigns due to new job policy By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases - TipRanks

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results - The Bakersfield Californian

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics board member resigns due to new job policy - Investing.com India

Nov 06, 2024

Nov 05, 2024

Long Term Trading Analysis for (COYA) - Stock Traders Daily

Nov 05, 2024

Nov 05, 2024

Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics - pharmabiz.com

Nov 05, 2024

Nov 01, 2024

Coya Therapeutics appoints new CEO amid Alzheimer's trial progress By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics, Inc. (NASDAQ:COYA) Sees Significant Increase in Short Interest - MarketBeat

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics appoints new CEO amid Alzheimer's trial progress - Investing.com

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics Promotes Arun Swaminathan, Ph.D. to Chief Executive Officer - citybiz

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer - StockTitan

Nov 01, 2024

Oct 31, 2024

Coya Therapeutics announces executive changes - Investing.com India

Oct 31, 2024

Oct 31, 2024

Coya Therapeutics Announces Leadership Change and New CEO - TipRanks

Oct 31, 2024

Oct 31, 2024

Coya Therapeutics announces executive changes By Investing.com - Investing.com UK

Oct 31, 2024

Oct 31, 2024

Coya Therapeutics On Developing A Combination Biologic - BioProcess Online

Oct 31, 2024

Oct 31, 2024

Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off (NASDAQ:COYA) - Seeking Alpha

Oct 31, 2024

Oct 30, 2024

Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results - Yahoo Finance

Oct 30, 2024

Oct 29, 2024

Coya Therapeutics reports promising Alzheimer's trial results By Investing.com - Investing.com South Africa

Oct 29, 2024

Oct 29, 2024

See the Impacts of Waco’s Walk to End Alzheimer’s - AOL

Oct 29, 2024

Oct 29, 2024

Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study - Yahoo Finance

Oct 29, 2024

Oct 29, 2024

Coya stock tumbles 23% on mixed results from Alzheimer's study - MSN

Oct 29, 2024

Oct 29, 2024

Coya stock tumbles 23% on mixed results from Alzheimer's study (NASDAQ:COYA) - Seeking Alpha

Oct 29, 2024

Oct 29, 2024

Companies Like Coya Therapeutics (NASDAQ:COYA) Can Afford To Invest In Growth - Simply Wall St

Oct 29, 2024

Oct 29, 2024

Coya Therapeutics reports positive immune response, safety in mid-stage Alzheimer's drug trial - Reuters

Oct 29, 2024

Oct 29, 2024

Coya Therapeutics reports promising Alzheimer's trial results - Investing.com

Oct 29, 2024

Oct 28, 2024

Coya Therapeutics Announces Conference Call to Report Results from an Investigator-Initiated Phase 2 Trial of Low-Dose Interleukin-2 in Patients with Mild to Moderate Alzheimer’s Disease - StockTitan

Oct 28, 2024

Oct 25, 2024

When (COYA) Moves Investors should Listen - Stock Traders Daily

Oct 25, 2024

Oct 22, 2024

Coya Therapeutics secures $10 million in private placement By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Coya Therapeutics Announces $10.0 Million Private Placement - citybiz

Oct 22, 2024

Oct 22, 2024

Coya Therapeutics Shares Rise 9% After $10 Million Private Placement - MarketWatch

Oct 22, 2024

Oct 22, 2024

Coya Therapeutics secures $10 million in private placement - Investing.com

Oct 22, 2024

Oct 22, 2024

Coya Therapeutics Announces $10M Private Placement to Advance Pipeline - TipRanks

Oct 22, 2024

Oct 14, 2024

Tips for preventing or delaying dementia - AOL

Oct 14, 2024

Oct 13, 2024

Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts - Seeking Alpha

Oct 13, 2024

Oct 08, 2024

Coya Therapeutics Chairman and CEO Howard Berman Selected for PharmaVoice 100 - citybiz

Oct 08, 2024

Oct 04, 2024

Exosomes Pipeline Dynamics 2024: FDA Approvals, Therapeutic - openPR

Oct 04, 2024

Oct 04, 2024

Exosomes Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, Latest FDA, EMA, and PMDA Approvals | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO - Barchart

Oct 04, 2024

Oct 04, 2024

How the (COYA) price action is used to our Advantage - Stock Traders Daily

Oct 04, 2024